cardioprotective therapy
Evidence-based pharmacologic interventions proven to reduce cardiovascular events and mortality.
Full Definition
Cardioprotective therapy encompasses medications that have demonstrated benefit in reducing cardiovascular morbidity and mortality through randomized controlled trials. Core components typically include statins for lipid management, ACE inhibitors or ARBs for blood pressure control and cardioprotection, antiplatelet therapy (primarily aspirin) for thrombotic event prevention, and beta-blockers in specific high-risk populations. The term emphasizes therapies with proven outcome benefits rather than surrogate endpoint improvements. Selection and dosing of cardioprotective agents should be individualized based on patient risk factors, comorbidities, and evidence-based guidelines. The concept extends beyond simple risk factor modification to encompass comprehensive cardiovascular risk reduction.
Usage
Usage note: Emphasizes evidence-based benefit; avoid using for unproven or theoretical cardiovascular benefits.
In Context
- "Optimal cardioprotective therapy was initiated including high-intensity statin and ACE inhibitor." — Discharge medication reconciliation
- "The patient's cardioprotective therapy regimen was reviewed and optimized at the follow-up visit." — Clinic visit documentation